HLB Life Science Decides to Absorb Subsidiary Aim Through Merger
[Asia Economy Reporter Myung-Hwan Lee] HLB Life Science announced on the 18th that it has decided to absorb and merge its subsidiary Aim to enhance shareholder value through increased management efficiency and the creation of financial synergies.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
- Nana Home Intruder Who Filed 'Counter Attempted Murder Complaint' Referred to Prosecution for False Accusation
- "Groups of 5 or More Now Restricted"... Unrelenting Running Craze Leaves Citizens and Police Exhausted
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
The merger ratio is 1 to 0, and the scheduled merger date is October 1.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
